Mirjam Weibel

938 total citations
10 papers, 791 citations indexed

About

Mirjam Weibel is a scholar working on Molecular Biology, Clinical Biochemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mirjam Weibel has authored 10 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Clinical Biochemistry and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mirjam Weibel's work include Advanced Glycation End Products research (4 papers), S100 Proteins and Annexins (4 papers) and Alzheimer's disease research and treatments (2 papers). Mirjam Weibel is often cited by papers focused on Advanced Glycation End Products research (4 papers), S100 Proteins and Annexins (4 papers) and Alzheimer's disease research and treatments (2 papers). Mirjam Weibel collaborates with scholars based in Switzerland, Germany and United States. Mirjam Weibel's co-authors include Claus W. Heizmann, Arnaud Galichet, Estelle Leclerc, G. Fritz, Emmanuel Sturchler, Hansruedi Büeler, Matthias Höchli, Stefano Ferrari, Beat W. Schäfer and Miro Makek and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Biochemical Journal.

In The Last Decade

Mirjam Weibel

10 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirjam Weibel Switzerland 9 514 296 144 131 86 10 791
Svetlana M. Nabokina United States 20 331 0.6× 97 0.3× 158 1.1× 264 2.0× 39 0.5× 36 981
Takaya Ishihara Japan 17 1.1k 2.2× 379 1.3× 71 0.5× 192 1.5× 26 0.3× 25 1.4k
Dae‐Yong Kim South Korea 11 538 1.0× 106 0.4× 51 0.4× 276 2.1× 53 0.6× 16 871
Boris Reljić Australia 14 961 1.9× 206 0.7× 80 0.6× 145 1.1× 55 0.6× 20 1.2k
Noriko Nomura Japan 15 385 0.7× 72 0.2× 43 0.3× 74 0.6× 40 0.5× 43 873
Svetlana Voronina United Kingdom 20 794 1.5× 48 0.2× 113 0.8× 144 1.1× 48 0.6× 34 1.6k
Bodo Brunner Germany 10 485 0.9× 76 0.3× 110 0.8× 73 0.6× 27 0.3× 19 921
Non Miyata Japan 17 807 1.6× 63 0.2× 76 0.5× 213 1.6× 40 0.5× 25 1.0k
Laurence Hubert France 21 742 1.4× 318 1.1× 22 0.2× 118 0.9× 42 0.5× 33 1.3k
Atsuko Kasahara Japan 12 823 1.6× 223 0.8× 73 0.5× 92 0.7× 35 0.4× 18 1.0k

Countries citing papers authored by Mirjam Weibel

Since Specialization
Citations

This map shows the geographic impact of Mirjam Weibel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam Weibel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam Weibel more than expected).

Fields of papers citing papers by Mirjam Weibel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjam Weibel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam Weibel. The network helps show where Mirjam Weibel may publish in the future.

Co-authorship network of co-authors of Mirjam Weibel

This figure shows the co-authorship network connecting the top 25 collaborators of Mirjam Weibel. A scholar is included among the top collaborators of Mirjam Weibel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjam Weibel. Mirjam Weibel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Galichet, Arnaud, Mirjam Weibel, & Claus W. Heizmann. (2008). Calcium-regulated intramembrane proteolysis of the RAGE receptor. Biochemical and Biophysical Research Communications. 370(1). 1–5. 89 indexed citations
2.
Sturchler, Emmanuel, Arnaud Galichet, Mirjam Weibel, Estelle Leclerc, & Claus W. Heizmann. (2008). Site-Specific Blockade of RAGE-VdPrevents Amyloid-β Oligomer Neurotoxicity. Journal of Neuroscience. 28(20). 5149–5158. 113 indexed citations
3.
Leclerc, Estelle, G. Fritz, Mirjam Weibel, Claus W. Heizmann, & Arnaud Galichet. (2007). S100B and S100A6 Differentially Modulate Cell Survival by Interacting with Distinct RAGE (Receptor for Advanced Glycation End Products) Immunoglobulin Domains. Journal of Biological Chemistry. 282(43). 31317–31331. 228 indexed citations
4.
Sturchler, Emmanuel, Jos A. Cox, Isabelle Durussel, Mirjam Weibel, & Claus W. Heizmann. (2006). S100A16, a Novel Calcium-binding Protein of the EF-hand Superfamily. Journal of Biological Chemistry. 281(50). 38905–38917. 62 indexed citations
5.
Ostendorp, Thorsten, Mirjam Weibel, Estelle Leclerc, et al.. (2006). Expression and purification of the soluble isoform of human receptor for advanced glycation end products (sRAGE) from Pichia pastoris. Biochemical and Biophysical Research Communications. 347(1). 4–11. 35 indexed citations
6.
Mueller, Andrea, Beat W. Schäfer, Stefano Ferrari, et al.. (2005). The Calcium-binding Protein S100A2 Interacts with p53 and Modulates Its Transcriptional Activity. Journal of Biological Chemistry. 280(32). 29186–29193. 125 indexed citations
8.
Kuenzle, Clive C., et al.. (1973). The reaction of bilirubin with diazomethane. Biochemical Journal. 133(2). 357–364. 21 indexed citations
10.
Kuenzle, Clive C., et al.. (1972). The purification of peptic antibody fragments from rabbit immunoglobulin G. Cellular and Molecular Life Sciences. 28(12). 1522–1523. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026